| 000 | 01502 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516005133.0 | ||
| 264 | 0 | _c20101210 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1784-3286 | ||
| 024 | 7 |
_a10.1179/acb.2010.052 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOumar, A A | |
| 245 | 0 | 0 |
_aGenotypic evaluation of etravirine sensitivity of clinical human immunodeficiency virus type 1 (HIV-1) isolates carrying resistance mutations to nevirapine and efavirenz. _h[electronic resource] |
| 260 |
_bActa clinica Belgica _c |
||
| 300 |
_a242-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzoxazines _xpharmacology |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNevirapine _xpharmacology |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 700 | 1 | _aJnaoui, K | |
| 700 | 1 | _aKabamba-Mukadi, B | |
| 700 | 1 | _aYombi, J C | |
| 700 | 1 | _aVandercam, B | |
| 700 | 1 | _aGoubau, P | |
| 700 | 1 | _aRuelle, J | |
| 773 | 0 |
_tActa clinica Belgica _gvol. 65 _gno. 4 _gp. 242-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1179/acb.2010.052 _zAvailable from publisher's website |
| 999 |
_c20257605 _d20257605 |
||